Showing results (111-120 of 159) with videos related to
Sort By:
Pageof 16
British Journal of Psychology (London, England : 1953)|July 8, 2009
Image descriptions in early and mid-level vision: what kind of model is this and what kind of models do we really need?M J Dry, N Kogo, T Putzeys, et al.Cognitive Science|December 7, 2011
Sampling assumptions in inductive generalizationDaniel J Navarro, Matthew J Dry, Michael D LeeClinical and Experimental Immunology|May 1, 1996
The allergenic properties of fresh and preserved Hevea brasiliensis latex protein preparationsR Kekwick, S Bhambri, M H Chabane, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|October 9, 1977
[Evaluation of the results of treatment of Graves' disease by synthetic antithyroid drugs]D Fischer, J Poncin, R Dunet, et al.British Journal of Clinical Pharmacology|March 1, 1979
Study of urinary excretion of butobarbitone in man in relation to the percentage of ideal body weightG Cheymol, C Bernheim, J Besson, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 12, 2008
Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergyN Abuaf, H Rostane, B Rajoely, et al.Annales De Dermatologie Et De Venereologie|January 28, 2009
[Safety of reintroducing platelet-inhibitory doses of aspirin in patients with urticaria or angioedema induced by anti-inflammatory doses]A Vial, P Mathelier-Fusade, H Gaouar, et al.The Journal of Allergy and Clinical Immunology|August 19, 1999
Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergyN Abuaf, B Rajoely, E Ghazouani, et al.Journal of Immunological Methods|September 27, 1993
Purification of human IgG4 subclass with allergen-specific blocking activityP Lambin, A Bouzoumou, M Murrieta, et al.Acta Psychiatrica Belgica|September 1, 1980
[Hormonal stimulation after injection of thyrotrophin releasing factor (TRF) and 1-24 ACTH in patients following chronic treatment with neuroleptics (author's transl)]J Dry, R Ardaillou, A Pradalier, et al.Pageof 16